CRIS

CURIS INC

CRIS·231269309·US·Common Stock·Healthcare - Biotechnology-13D/G

CRIS (CURIS INC) is held by 25 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($204,756), RENAISSANCE TECHNOLOGIES LLC ($200,717), MORGAN STANLEY ($139,149). Net institutional sentiment: Mixed.

25
Holders
Avg rating(6 Elite)
$841,679
Total Value
63% (31)
Fund Consensus
15 buying - 9 selling
CRISSmart Money Verdict
View all
Held by 25 funds
6 elite
Who's Trading
ActivistARArmistice Capital, LLC5.0%May 15, 2026
ActivistTAThomas A. Satterfield, Jr.9.9%May 14, 2026
ActivistNANantahala Capital Management, LLC10.0%Apr 24, 2026
ActivistNPNANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP7.0%Apr 7, 2026
InsiderKIKAITIN KENNETH IBuy $5KMar 31, 2026
ActivistSTStonepine Capital Management, LLC9.9%Mar 27, 2026
ActivistM2M28 Capital Management LP4.8%Jan 23, 2026
ActivistMaverick Capital, Ltd.Maverick Capital, Ltd.0.4%Nov 14, 2025
ActivistARArmistice Capital, LLC10.0%Aug 14, 2025
ActivistBLBleichroeder LP9.9%Mar 31, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
374,326$204,7560.0%+401.01%
35
Increased
366,740(+52.2%)$200,7170.0%-54.47%
32
Increased
254,245(+4459x)$139,1490.0%+400.35%
24
Increased
168,327(+66.1%)$92,1330.0%-87.44%
22
Increased
67,018(+41.9%)$36,6790.0%+393.97%
18
New
61,664$33,7300.0%+401.01%
30
Decreased
58,035(-32.9%)$31,7630.0%+183.38%
0
Unchanged
53,484$29,2720.0%+57.96%
0
New
35,400$19,3740.0%+401.01%
28
Increased
26,295(+3.8%)$14,3920.0%+261.09%
13
Increased
23,977(+11.1%)$13,1230.0%+44.78%
13
Unchanged
21,049$11,5200.0%-61.10%
0
Unchanged
49,554$6,1940.0%-96.20%
0
Unchanged
10,492$5,7420.0%-29.86%
0
Increased
2,597(+62.6%)$1,4210.0%+174.35%
11
New
1,541$8430.0%+401.01%
17
New
700$3830.0%+401.01%
17
Unchanged
450$2460.0%-92.25%
0
Unchanged
120$670.0%+114.35%
0
Unchanged
108$550.0%+57.96%
0

Showing 1-20 of 31

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used